138 related articles for article (PubMed ID: 27451500)
21. A novel highly reproducible and lethal nonhuman primate model for orthopox virus infection.
Kramski M; Mätz-Rensing K; Stahl-Hennig C; Kaup FJ; Nitsche A; Pauli G; Ellerbrok H
PLoS One; 2010 Apr; 5(4):e10412. PubMed ID: 20454688
[TBL] [Abstract][Full Text] [Related]
22. Smallpox in the Post-Eradication Era.
Meyer H; Ehmann R; Smith GL
Viruses; 2020 Jan; 12(2):. PubMed ID: 31991671
[TBL] [Abstract][Full Text] [Related]
23. Tecovirimat, a p37 envelope protein inhibitor for the treatment of smallpox infection.
Duraffour S; Andrei G; Snoeck R
IDrugs; 2010 Mar; 13(3):181-91. PubMed ID: 20191435
[TBL] [Abstract][Full Text] [Related]
24. Drug Approved to Treat Smallpox After a Bioterrorist Attack.
Aschenbrenner DS
Am J Nurs; 2018 Nov; 118(11):21. PubMed ID: 30358593
[No Abstract] [Full Text] [Related]
25. Progression of pathogenic events in cynomolgus macaques infected with variola virus.
Wahl-Jensen V; Cann JA; Rubins KH; Huggins JW; Fisher RW; Johnson AJ; de Kok-Mercado F; Larsen T; Raymond JL; Hensley LE; Jahrling PB
PLoS One; 2011; 6(10):e24832. PubMed ID: 21998632
[TBL] [Abstract][Full Text] [Related]
26. Ectromelia Virus Disease Characterization in the BALB/c Mouse: A Surrogate Model for Assessment of Smallpox Medical Countermeasures.
Garver J; Weber L; Vela EM; Anderson M; Warren R; Merchlinsky M; Houchens C; Rogers JV
Viruses; 2016 Jul; 8(7):. PubMed ID: 27455306
[TBL] [Abstract][Full Text] [Related]
27. The development and approval of tecoviromat (TPOXX
Merchlinsky M; Albright A; Olson V; Schiltz H; Merkeley T; Hughes C; Petersen B; Challberg M
Antiviral Res; 2019 Aug; 168():168-174. PubMed ID: 31181284
[TBL] [Abstract][Full Text] [Related]
28. Tecovirimat for smallpox infections.
Bolken TC; Hruby DE
Drugs Today (Barc); 2010 Feb; 46(2):109-17. PubMed ID: 20393639
[TBL] [Abstract][Full Text] [Related]
29. In vitro efficacy of brincidofovir against variola virus.
Olson VA; Smith SK; Foster S; Li Y; Lanier ER; Gates I; Trost LC; Damon IK
Antimicrob Agents Chemother; 2014 Sep; 58(9):5570-1. PubMed ID: 24957837
[TBL] [Abstract][Full Text] [Related]
30. [We should be prepared to smallpox re-emergence.].
Shchelkunov SN; Shchelkunova GA
Vopr Virusol; 2019; 64(5):206-214. PubMed ID: 32167685
[TBL] [Abstract][Full Text] [Related]
31. Smallpox research activities: U.S. interagency collaboration, 2001.
LeDuc JW; Damon I; Relman DA; Huggins J; Jahrling PB
Emerg Infect Dis; 2002 Jul; 8(7):743-5. PubMed ID: 12095449
[No Abstract] [Full Text] [Related]
32. Preliminary Screening and In Vitro Confirmation of Orthopoxvirus Antivirals.
Grosenbach DW; Hruby DE
Methods Mol Biol; 2019; 2023():143-155. PubMed ID: 31240676
[TBL] [Abstract][Full Text] [Related]
33. Oral Tecovirimat for the Treatment of Smallpox.
Grosenbach DW; Honeychurch K; Rose EA; Chinsangaram J; Frimm A; Maiti B; Lovejoy C; Meara I; Long P; Hruby DE
N Engl J Med; 2018 Jul; 379(1):44-53. PubMed ID: 29972742
[TBL] [Abstract][Full Text] [Related]
34. Smallpox: the old and the new.
Griffiths PD
Rev Med Virol; 2004; 14(5):273-4. PubMed ID: 15334535
[No Abstract] [Full Text] [Related]
35. Treatment of lethal vaccinia virus respiratory infections in mice with cidofovir.
Smee DF; Bailey KW; Sidwell RW
Antivir Chem Chemother; 2001 Jan; 12(1):71-6. PubMed ID: 11437324
[TBL] [Abstract][Full Text] [Related]
36. Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods.
Bell TM; Facemire P; Bearss JJ; Raymond JL; Chapman J; Zeng X; Shamblin JD; Williams JA; Grosenbach DW; Hruby DE; Damon IK; Goff AJ; Mucker EM
PLoS Pathog; 2024 Feb; 20(2):e1012007. PubMed ID: 38386661
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of Pathological and Virological Findings During Experimental Calpox Virus Infection of Common Marmosets (Callithrix jacchus).
Schmitt A; Gan LL; Abd El Wahed A; Shi T; Ellerbrok H; Kaup FJ; Stahl-Hennig C; Mätz-Rensing K
Viruses; 2017 Nov; 9(12):. PubMed ID: 29182537
[TBL] [Abstract][Full Text] [Related]
38. A mouse model of lethal infection for evaluating prophylactics and therapeutics against Monkeypox virus.
Stabenow J; Buller RM; Schriewer J; West C; Sagartz JE; Parker S
J Virol; 2010 Apr; 84(8):3909-20. PubMed ID: 20130052
[TBL] [Abstract][Full Text] [Related]
39. On the origin of smallpox: correlating variola phylogenics with historical smallpox records.
Li Y; Carroll DS; Gardner SN; Walsh MC; Vitalis EA; Damon IK
Proc Natl Acad Sci U S A; 2007 Oct; 104(40):15787-92. PubMed ID: 17901212
[TBL] [Abstract][Full Text] [Related]
40. Exploring the potential of variola virus infection of cynomolgus macaques as a model for human smallpox.
Jahrling PB; Hensley LE; Martinez MJ; Leduc JW; Rubins KH; Relman DA; Huggins JW
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15196-200. PubMed ID: 15477589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
